About Us

Founded in 2018, Lyratone Technologies specializes in the research and development of cutting-edge hearing health solutions. By integrating Software-Defined Hearing (SDH) and artificial intelligence with advanced acoustic technology, we are redefining the future of hearing aids. Our team, composed primarily of experts in cloud computing, AI, and medical hearing technology, is committed to breaking traditional barriers through forward-thinking innovation.

Believe in better hearing for better life, Lyratone keep exploring the cutting-edge technology and reach for more possibility in the hearing health category. Forming a reliable partnership with our client, we hope to provide hearing loss patients with high-tech, affordable choices, open up a channel to this wonderful world.

Lyratone focuses on the B2B market, providing enterprise customers with full-stack medical hearing aid and assistive hearing solutions. Our offerings include hearing aid algorithms, integrated motherboards, complete device solutions, and hearing fitting and tuning software. We provide end-to-end technical support—from research and development to application, and from software to hardware—ensuring seamless integration of our technology into partner products. Our hearing aids are certified as Class II medical devices by the US FDA, reinforcing our commitment to quality and compliance.

At the heart of our innovation is the globally pioneering Software-Defined Hearing (SDH) architecture, which disrupts traditional hardware-based hearing aids. This software-driven approach allows for rapid technological iteration and seamless scalability, enabling continuous advancements in performance. Our multidisciplinary expertise spans acoustics, circuitry, and AI algorithms, allowing us to develop groundbreaking hearing technologies that adapt to users' needs in real time.

Lyratone Technologies was founded, marking the beginning of our commitment to innovation in hearing technology.

The Lyratone Hearing App was launched on the Apple and Android app stores. Utilizing smartphone computing power, the app introduced WDRC and noise reduction hearing functions. It was one of the first apps to combine both hearing test and hearing aid capabilities. To date, the app has reached approximately 250,000 users. This was also the year we developed our first hearing aid, based on the Software-Defined Hearing (SDH) architecture. Simultaneously, Lyratone began R&D on embedded hearing systems using general-purpose System on Chip (SoC) platforms.

Lyratone released the first commercial version of the LyraOS embedded hearing SDK. Based on SDH architecture, this solution enabled one of top-tier earbud manufacturers to integrate advanced hearing features into their consumer electronics.

Lyratone made significant enhancements to LyraOS, improving its performance for prescription air conduction hearing aids built on the SDH architecture.

Lyratone launched its first full-device air conduction hearing aid, receiving FDA OTC certification. This device utilized 32-band WDRC technology and 12 nm chipset, offering superior sound quality and clarity.

Lyratone introduced its first bone conduction hearing aid, developed in collaboration with a strategic partner. Lyratone provided the core PCBA board, embedded with the LyraOS hearing algorithms SDK. Additionally, we completed the development of open-ear hearing aids, further expanding our product portfolio.

Lyratone continues to innovate, focusing on air conduction, bone conduction, and open-ear hearing aids for enterprise customers. All our products are built on the SDH architecture with a 12nm chipset, a significant advancement over the traditional hardware-defined hearing architecture, which typically uses a 56nm chipset. This ensures cutting-edge performance and scalability.